Accueil   Diary - News   All news PRAGMA Therapeutics wins the 2016 Innovation Award from MassChallenge Switzerland

PRAGMA Therapeutics wins the 2016 Innovation Award from MassChallenge Switzerland


May 26, 2016 – Archamps, France – PRAGMA Therapeutics announced that the company has received the 2016 Innovation Award from MassChallenge Switzerland at the last edition of the Brain Forum held on May 26-27th at the Swiss Convention Center in Lausanne. Selected from the 120 most innovative European biotech and medtech start-ups in Neuroscience, and within the top 6 finalists, PRAGMA Therapeutics presented its unique asset for the treatment of post-traumatic disorders and hearing loss in front of 1000+ worldwide peer neuroscientists, institutional and life-science organizations, investors and pharma industries.

 

“We are very grateful to the Brain Forum Innovation Award selection committee and MassChallenge Switzerland for this prestigious award, which highlight our deep commitment in advancing innovative medicines for severe brain and ear disorders” commented Sylvain Celanire, CEO of Pragma Therapeutics.

 

Together with other 71 international high impact startups, PRAGMA Therapeutics will integrate the MassChallenge Switzerland acceleration program this summer in Renens-CH, and will access free office space, prototyping and wet lab, and will benefit from high profile coaching and mentorship from worldwide MassChallenge. Nearly 1 million CHF will be awarded to the successful winner of the MassChallenge Switzerland competition to be held in November 2016.

 

 

About Brain Forum:

 

The Brain Forum was founded by Dr. Walid Juffali, businessman, entrepreneur, scientist and philanthropist, as part of the W Science Initiative, to help progress the field of brain research. This growing body of knowledge holds the key, not just to the development of new treatments for neurological disorders, but to a broad range of applications that could transform the way we live and work. For more information, visit www.thebrainforum.org.

 

About MassChallenge:

 

MassChallenge is the most startup-friendly accelerator on the planet. No equity and not-for-profit, we are obsessed with helping entrepreneurs across any industry. We also reward the highest-impact startups through a competition to win a portion of several million dollars in equity-free cash awards. Through our global network of accelerators in Boston, London and Jerusalem and unrivalled access to our corporate partners, we can have a massive impact – driving growth and creating value the world over. To date, the 835 MassChallenge alumni have raised over $1.3 billion in funding, generated over $575 million in revenue and created over 8,500 jobs. For more information, visit www.masschallenge.org.

 

 

About MassChallenge Switzerland:

 

The accelerator will combine MassChallenge’s no-equity, competition-based model with the talent and potential of Swiss startup ecosystem. Based in the Lake Geneva Region, the accelerator attracts startups from Switzerland, other parts of Europe and beyond, who want to understand and access Switzerland’s unique innovation culture and progress in high technology. Six founding partners are supporting the MassChallenge Switzerland launch: Bühler Group, already a diamond sponsor of MassChallenge in Boston, Nestlé, Inartis Foundation, the Swiss Economic Forum, Foundation Bailly, and Givaudan. A high-profile supervisory board has been formed to launch MassChallenge Switzerland in 2016. Members include Stefan Catsicas, Executive Vice President Nestlé S.A., CTO; Calvin Grieder, Chairman of the Board of Directors & CEO Bühler Group; Benoît Dubuis, Director of Campus Biotech and President of the Inartis Foundation; Peter Stähli, Chairman of the Swiss Economic Forum Group; Chris Thoen, Sr VP Head of Global Science and Technology Givaudan SA; and John Harthorne, CEO of MassChallenge.

 

 

 IMG_2634 (2)

 

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree